Nanomedicine delivers targeted antibiotic at one go to fight infection
HQ Team October 25, 2024: Researchers at the University of Waterloo have unveiled a nanomedicine that can deliver an entire course of antibiotics.
Drugs
Medical
Pharma
Drugs
Health
Pharma
Ketamine pill may revolutionize treatment for hard-to-treat depression
HQ Team October 25, 2024: A recent study indicates that a new slow-release ketamine pill could offer a promising alternative for individuals suffering.
Drugs
Health
Pharma
Merck acquires Yale University spinout Modifi Biosciences for up to $1.3 billion
Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to.
Drugs
Health
Pharma
CDMO Samsung Biologics signs $1.24 billion drug manufacturing deal
Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.
Drugs
Health
Pharma
US drug regulator FDA approves expanded use of Pfizer’s RSV vaccine
The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.
Health
Medical
Pharma
New portable handheld device delivers blood test results in an hour
HQ Team October 22, 2024: A new handheld device can isolate biomarkers for different diseases using sound waves from a single drop of.
Drugs
Health
Pharma
Novo’s type 2 oral diabetic drug cuts heart diseases by 14% in a trial
Danish pharmaceutical company, Novo Nordisk’s oral semaglutide drug to treat type 2 diabetes helped reduce heart diseases by 14% compared to a dummy.
Drugs
Health
Pharma
Egypt gets WHO certification for being a malaria-free country
Malaria, which plagued the ancient pharaohs, has been eliminated in Egypt, according to a World Health Organization-certificate, — the third such in in.
Drugs
Health
Pharma
Astellas Pharma gets US regulator’s nod for its gastric cancer drug
Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.
Drugs
Health
Pharma
Gilead’s end-stage confirmatory trials of bladder cancer drug fail
Gilead Sciences, Inc. has withdrawn its bladder cancer drug from the US market and stopped its confirmatory clinical trial after it failed to.